UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000015332
Receipt No. R000017828
Official scientific title of the study Efficacy of Durable Arrhythmogenic Pulmonary Vein Isolation on Initial Procedural Success in Patients Undergoing Atrial Fibrillation Ablation
Date of disclosure of the study information 2014/10/03
Last modified on 2016/07/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of Durable Arrhythmogenic Pulmonary Vein Isolation on Initial Procedural Success in Patients Undergoing Atrial Fibrillation Ablation
Title of the study (Brief title) DRAGON study
Region
Japan

Condition
Condition atrial fibriilation
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the efficacy of additional pulmonary vein antrum ablation
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes recurrence of atrial fibrillation
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 extensive encircling pulmonary vein isolation
Interventions/Control_2 adding a segmental ablation line surrounding arrhythmogenic pulmonary vein
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients undergoing initial ablation for paroxysmal or persistent (duration < 1 year) atrial fibrillation
Key exclusion criteria age < 20 years old, pregnancy, history of cardiac surgery, history of catheter ablation, significant valvular disease
Target sample size 168

Research contact person
Name of lead principal investigator Masaharu Masuda
Organization Kansai Rosai Hospital
Division name Cardiovascular center
Address 3-1-69, Inabaso, Amagasaki, Hyogo
TEL 06-6416-1221
Email masuda101@gmail.com

Public contact
Name of contact person Masaharu Masuda
Organization Kansai Rosai Hospital
Division name Cardiovascular center
Address 3-1-69, Inabaso, Amagasaki, Hyogo
TEL 06-6416-1221
Homepage URL
Email masuda101@gmail.com

Sponsor
Institute Kansai Rosai Hospital
Institute
Department

Funding Source
Organization Kansai Rosai Hospital
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 03 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2014 Year 09 Month 01 Day
Anticipated trial start date
2014 Year 10 Month 03 Day
Last follow-up date
2016 Year 11 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 10 Month 03 Day
Last modified on
2016 Year 07 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017828